Alcohol Effects on Impulsivity in Alcoholism
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the relationship between impulsivity, personal reactions to alcohol, and Alcohol Use Disorder in young adults. Researchers aim to discover new prevention and treatment methods by reducing impulsivity and the desire to drink. Participants will attend sessions where they receive alcohol and a placebo (a substance with no active effect) to better understand these connections. This trial may suit individuals aged 21-25 who drink regularly and have reached a blood alcohol level above .08% at least once in the last month. As an Early Phase 1 trial, this research focuses on understanding how these interventions work in people, offering participants a chance to contribute to groundbreaking insights.
Will I have to stop taking my current medications?
If you are currently taking psychotropic medications (drugs that affect your mood, thoughts, or behavior), you will need to stop, as the trial excludes those who are using them or have a prescription for them in the past 30 days.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that administering alcohol through an IV in a controlled setting is common in studies. These studies often compare alcohol to a placebo, such as a saltwater solution, to observe reactions. Some research suggests that impulsiveness may influence how people respond to alcohol. Other studies have found that the brain reacts less to alcohol after repeated exposure.
Generally, alcohol is well-tolerated in these study settings, though side effects can occur. Participants might experience dizziness or nausea, but these effects are usually mild and temporary. The studies are designed to closely monitor participants, ensuring their safety during the trial. Although this trial is in the early stages of research, the controlled environment helps manage any risks.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how alcohol affects impulsivity in individuals with alcoholism through a unique method. Unlike typical treatments that might involve medications or behavioral therapies to manage alcohol dependency, this approach uses controlled intravenous administration of alcohol and placebo to observe changes in impulsivity. This method allows scientists to directly study the immediate effects of alcohol on behavior, providing insights that could lead to more effective interventions for managing impulsivity in alcoholism. By understanding these dynamics, the trial could pave the way for new strategies to help individuals with alcoholism make better decisions, potentially reducing relapse rates.
What evidence suggests that this trial's treatments could be effective for Alcohol Use Disorder?
This trial will explore the effects of alcohol on impulsivity and subjective response in individuals with Alcohol Use Disorder (AUD). Participants in one arm of the trial will receive alcohol followed by a placebo, then engage in a free-access session to self-administer alcohol and placebo. In the other arm, participants will receive a placebo followed by alcohol, with a similar free-access session. Research has shown that impulsivity and subjective responses to alcohol are connected in ways that might predict or influence AUD. Studies have found that more impulsive individuals often feel more energized and less relaxed after drinking, especially in large quantities. Another study discovered that individuals who felt less control over their drinking reached higher blood alcohol levels when they received alcohol through an IV. These findings suggest that impulsivity and subjective responses to alcohol could be important areas to focus on for developing new treatments to reduce risky drinking behaviors.14678
Who Is on the Research Team?
Jessica Weafer, PhD
Principal Investigator
Ohio State University
Are You a Good Fit for This Trial?
This trial is for young adults aged 21-25 who drink alcohol frequently, reaching a blood alcohol concentration (BAC) of over .08% at least once in the past month. Participants must have been drinking at least twice weekly in the last month and be fluent in English.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Lab Sessions
Participants complete two intravenous administration sessions in the lab receiving alcohol and placebo, followed by a third session with free-access to self-administer alcohol and placebo
Daily Assessment
Participants engage in seven 10-day daily assessment periods using ecological momentary assessment (EMA) to report alcohol consumption and subjective response
Follow-up
Participants are monitored for safety and effectiveness after the main trial activities
What Are the Treatments Tested in This Trial?
Interventions
- Impulsivity Domains and Subjective Response
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jessica Weafer
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator